Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Methyl adipoyl chloride is a chemical compound synthesized from adipoyl chloride, a derivative of adipic acid, by replacing one of the hydrogen atoms with a methyl group. It serves as a key intermediate in the production of various polymers, plastics, and other materials, making it an important chemical in the industrial and manufacturing sectors.

35444-44-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 35444-44-1 Structure
  • Basic information

    1. Product Name: METHYL ADIPOYL CHLORIDE
    2. Synonyms: Hexanoic acid, 6-chloro-6-oxo-, methyl ester;Methyl 5-(chloroformyl)pentanoate;Methyl 6-chloro-6-oxohexanoate;Methyl adipyl chloride;METHYL ADIPOYL CHLORIDE;METHYL 5-(CHLOROFORMYL)VALERATE;ADIPIC ACID MONOMETHYL ESTER CHLORIDE;mono-Methyl adipoyl chloride
    3. CAS NO:35444-44-1
    4. Molecular Formula: C7H11ClO3
    5. Molecular Weight: 178.61
    6. EINECS: 252-569-1
    7. Product Categories: N/A
    8. Mol File: 35444-44-1.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 76 °C0.8 mm Hg(lit.)
    3. Flash Point: >230 °F
    4. Appearance: /
    5. Density: 1.149 g/mL at 20 °C(lit.)
    6. Vapor Pressure: 0.186mmHg at 25°C
    7. Refractive Index: n20/D 1.4470(lit.)
    8. Storage Temp.: Inert atmosphere,Room Temperature
    9. Solubility: N/A
    10. Sensitive: Moisture Sensitive
    11. BRN: 1766187
    12. CAS DataBase Reference: METHYL ADIPOYL CHLORIDE(CAS DataBase Reference)
    13. NIST Chemistry Reference: METHYL ADIPOYL CHLORIDE(35444-44-1)
    14. EPA Substance Registry System: METHYL ADIPOYL CHLORIDE(35444-44-1)
  • Safety Data

    1. Hazard Codes: C
    2. Statements: 34
    3. Safety Statements: 26-36/37/39-45
    4. RIDADR: UN 3265 8/PG 3
    5. WGK Germany: 3
    6. RTECS:
    7. HazardClass: 8
    8. PackingGroup: II
    9. Hazardous Substances Data: 35444-44-1(Hazardous Substances Data)

35444-44-1 Usage

Uses

Used in Polymer and Plastics Production:
Methyl adipoyl chloride is used as a key intermediate for the production of polyamide resins and polyesters. These materials are widely used in the manufacturing of fibers, plastics, and films, contributing to the versatility and functionality of various products.
Used in Pharmaceutical Production:
Methyl adipoyl chloride is utilized in the synthesis of pharmaceuticals, playing a crucial role in the development of new drugs and medications that can address various health conditions and improve patient outcomes.
Used in Agrochemical Production:
Methyl adipoyl chloride is also employed in the production of agrochemicals, which are essential for enhancing crop protection, increasing agricultural productivity, and ensuring food security.

Check Digit Verification of cas no

The CAS Registry Mumber 35444-44-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,5,4,4 and 4 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 35444-44:
(7*3)+(6*5)+(5*4)+(4*4)+(3*4)+(2*4)+(1*4)=111
111 % 10 = 1
So 35444-44-1 is a valid CAS Registry Number.
InChI:InChI=1/C7H11ClO3/c1-11-7(10)5-3-2-4-6(8)9/h2-5H2,1H3

35444-44-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (L04377)  Methyl adipoyl chloride, 96%   

  • 35444-44-1

  • 2g

  • 319.0CNY

  • Detail
  • Alfa Aesar

  • (L04377)  Methyl adipoyl chloride, 96%   

  • 35444-44-1

  • 10g

  • 1051.0CNY

  • Detail
  • Alfa Aesar

  • (L04377)  Methyl adipoyl chloride, 96%   

  • 35444-44-1

  • 50g

  • 3307.0CNY

  • Detail
  • Aldrich

  • (638560)  Methyladipoylchloride  97%

  • 35444-44-1

  • 638560-5G

  • 720.72CNY

  • Detail

35444-44-1Relevant articles and documents

An antibody-catalyzed isomerization reaction

Uno,Ku,Prudent,Huang,Schultz

, p. 3811 - 3817 (1996)

Monoclonal antibodies (mAbs) were generated against the coplanar transition state (TS(paragraph)) analogue 1 and assayed for their ability to catalyze the isomerization of bridged biphenyls 4, 6, and 7. This is a relatively simple unimolecular reaction whose activation barrier arises from unfavorable steric interactions between the two benzylic methylene groups and strain in the bridging ring system. Seven mAbs were found that catalyzed the isomerization of 4 to 6; the most efficient (mAb 64D8E10) has k(cat) and K(M) values of 4.3 x 10-5 s-1 and 420 μM, respectively. This corresponds to a rate enhancement over the unimolecular uncatalyzed reaction (k(cat)/k(uncat)) of 2900. The dissociation constant for the TS(paragraph) analogue, K(d), was determined to be 210 nM. For both the antibody (64D8E10) catalyzed and uncatalyzed reactions, the free energy of activation (ΔG(paragraph)) is comprised largely of the enthalpy term; the antibody decreases the enthalpy of activation by 5 kcal/mol. Despite relatively large differences in the values of k(cat)/k(uncat) for the five antibodies, the ratios of K(d) to K(M)(4) are very similar. It is likely that the antibodies catalyze this reaction by reducing both ring strain and nonbonded steric interactions in the transition state.

ω-oxidation of α-chlorinated fatty acids: Identification of α-chlorinated dicarboxylic acids

Brahmbhatt, Viral V.,Albert, Carolyn J.,Anbukumar, Dhanalakshmi S.,Cunningham, Bryce A.,Neumann, William L.,Ford, David A.

, p. 41255 - 41269 (2010)

Myeloperoxidase-derived HOCl targets tissue- and lipoprotein- associated plasmalogens to generate α-chlorinated fatty aldehydes, including 2-chlorohexadecanal. Under physiological conditions, 2-chlorohexadecanal is oxidized to 2-chlorohexadecanoic acid (2-ClHA). This study demonstrates the catabolism of 2-ClHA by ω-oxidation and subsequent β-oxidation from the ω-end. Mass spectrometric analyses revealed that 2-ClHA is ω-oxidized in the presence of liver microsomes with initial ω-hydroxylation of 2-ClHA. Subsequent oxidation steps were examined in a human hepatocellular cell line (HepG2). Three different α-chlorinated dicarboxylic acids, 2-chlorohexadecane-(1,16)- dioic acid, 2-chlorotetradecane- (1,14)-dioic acid, and 2-chloroadipic acid (2-ClAdA), were identified. Levels of 2-chlorohexadecane-( 1,16)-dioic acid, 2-chlorotetradecane-(1,14)-dioic acid, and 2-ClAdA produced by HepG2 cells were dependent on the concentration of 2-ClHA and the incubation time. Synthetic stable isotope-labeled 2-ClHA was used to demonstrate a precursorproduct relationship between 2-ClHA and the α-chlorinated dicarboxylic acids. We also report the identification of endogenous 2-ClAdA in human and rat urine and elevations in stable isotopelabeled urinary 2-ClAdA in rats subjected to intraperitoneal administration of stable isotope-labeled 2-ClHA. Furthermore, urinary 2-ClAdA and plasma 2-ClHA levels are increased in LPStreated rats. Taken together, these data show that 2-ClHA is ω-oxidized to generate α-chlorinated dicarboxylic acids, which include α-chloroadipic acid that is excreted in the urine.

A synthesis and properties of new 4,4-difluoro-3a,4a- diaza-s-indacene (BODIPY)-labeled lipids

Boldyrev,Molotkovsky, Jul G.

, p. 78 - 83 (2006)

A series of fluorescently labeled fatty acids of various chain lengths with 4,4-difluoro-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene-8-yl (Me 4-BODIPY-8) residue in the ω-position were synthesized. These acids were used to prepare new fluorescently labeled phosphatidylcholines, sphingomyelin, and galactosyl ceramide. The symmetry of the Me 4-BODIPY-8-fluorophore suggests that, in most bilayer membrane systems, this fluorophore would be embedded into the bilayer. Pleiades Publishing, Inc., 2006.

BODIPYs revealing lipid droplets as valuable targets for photodynamic theragnosis

Agarrabeitia, Antonia R.,De La Moya, Santiago,García-Garrido, Fernando,García-Moreno, Inmaculada,Ortiz, María J.,Palao, Eduardo,Prieto-Casta?eda, Alejandro,Tabero, Andrea,Villanueva, Angeles

, p. 940 - 943 (2020)

Endowing BODIPY PDT agents with the ability to probe lipid droplets is demonstrated to boost their phototoxicity, allowing the efficient use of highly fluorescent dyes (poor ROS sensitizers) as phototoxic agents. Conversely, this fact opens the way to the development of highly bright ROS photosensitizers for performing photodynamic theragnosis (fluorescence bioimaging and photodynamic therapy) from a single simple agent. On the other hand, the noticeable capability of some of the reported dyes to probe lipid droplets in different cell lines under different conditions reveals their use as privileged probes for advancing the study of interesting lipid droplets by fluorescence microscopy.

Synthesis of the 4-aza cyclopentenone analogue of Δ12,14-15-deoxy-PGJ2 and S-cysteine adducts

Conway, Lorna,Riccio, Anna,Santoro, M. Gabriella,Evans, Paul

, (2020)

The synthesis of a series of 4-aza cross-conjugated cyclopentenones, inspired by the natural prostaglandin Δ12,14-15-deoxy-PGJ2 (5) is described. Using the 4-aza cyclopentenone 7, the installation of the α-side chain was performed using N-functionalisation, following a Boc-deprotection. The ω-side chain was then installed through a Baylis-Hillman type aldol reaction with trans-2-octenal. This afforded 11, the aza-analogue of 5. With this prostaglandin analogue in hand, a series of thiol adducts (14–16) were prepared. Included are activities for compounds 11 and 14–16 in relation to inhibition of the transcription factor NF-κB.

New protoilludane sesquiterpenes from Lactarius violascens

Vidari, Giovanni,Garlaschelli, Luigi,Rossi, Alessandra,Vita-Finzi, Paola

, p. 1957 - 1960 (1998)

Violascensol 1 and the corresponding 6-ketostearoyl ester 2 were isolated from the fruiting bodies of Lactarius violascens. Their structures were established by spectroscopic and chemical methods. Compounds 1 and 2 are the first examples of protoilludane sesquiterpenes isolated from a Lactarius species.

Neutrophil-Selective Fluorescent Probe Development through Metabolism-Oriented Live-Cell Distinction

Gao, Min,Lee, Sun Hyeok,Park, Sang Hyuk,Ciaramicoli, Larissa Miasiro,Kwon, Haw-Young,Cho, Heewon,Jeong, Joseph,Chang, Young-Tae

supporting information, p. 23743 - 23749 (2021/10/14)

Human neutrophils are the most abundant leukocytes and have been considered as the first line of defence in the innate immune system. Selective imaging of live neutrophils will facilitate the in situ study of neutrophils in infection or inflammation events as well as clinical diagnosis. However, small-molecule-based probes for the discrimination of live neutrophils among different granulocytes in human blood have yet to be reported. Herein, we report the first fluorescent probe NeutropG for the specific distinction and imaging of active neutrophils. The selective staining mechanism of NeutropG is elucidated as metabolism-oriented live-cell distinction (MOLD) through lipid droplet biogenesis with the help of ACSL and DGAT. Finally, NeutropG is applied to accurately quantify neutrophil levels in fresh blood samples by showing a high correlation with the current clinical method.

Aziridine-2-carboxylic acid derivatives and its open-ring isomers as a novel PDIA1 inhibitors

Leite, Irena,Andrianov, Victor,Zelencova-Gopejenko, Diana,Loza, Einars,Kazhoka-Lapsa, Iveta,Domracheva, Ilona,Stoyak, Marta,Chlopicki, Stefan,Kalvins, Ivars

, p. 1086 - 1106 (2022/01/12)

[Figure not available: see fulltext.] Acyl derivatives of aziridine-2-carboxylic acid have been synthesized and tested as PDIA1 inhibitors. Calculations of charge value and distribution in aziridine ring system and some alkylating agents were performed. For the first time was found that acyl derivatives of aziridine-2-carboxylic acid are weak to moderately active PDIA1 inhibitors.

Design, synthesis and biological evaluation of novel indazole-based derivatives as potent HDAC inhibitors via fragment-based virtual screening

Gao, Liang,Gao, Lina,He, Fengjun,Hu, Lihong,Kang, Di,Liu, Jian,Wang, Ping,Wen, Yu,Zhou, Jingxian

, (2020/03/10)

Based on fragment-based virtual screening and bioisoterism strategies, novel indazole and pyrazolo[3,4-b] pyridine derivatives as HDACs inhibitors were designed, synthesized and evaluated. Most of these compounds displayed good to excellent inhibitory activities against HDACs, especially compounds 15k and 15m were identified as potent inhibitors of HDAC1 (IC50 = 2.7 nM and IC50 = 3.1 nM), HDAC2 (IC50 = 4.2 nM and IC50 = 3.6 nM) and HDAC8 (IC50 = 3.6 nM and IC50 = 3.3 nM). Further anti-proliferation assays revealed that compounds 15k and 15m showed better anti-proliferative activities against HCT-116 and HeLa cells than positive control SAHA. The western blot analysis results indicated that compounds 15k and 15m noticeably up-regulated the level of acetylated α-tubulin and histone H3. In addition, the two compounds 15k and 15m could arrest cell cycle in G2/M phase and promote cell apoptosis, which was similar as the reference compound SAHA. Through the molecular docking and dynamic studies, the potent HDAC inhibitory activities mainly caused by van der Waals and electrostatic interactions with the HDACs.

Cationic lipid molecule, and application thereof in nucleic acid delivery

-

Paragraph 0149-0152, (2019/10/08)

The present invention discloses a cationic lipid molecule, and an application thereof in nucleic acid delivery. The structural formula of the cationic lipid molecule is represented by formula i. The invention further provides a cationic liposome, a lipid compound, a reagent, a kit, a preparation and a medicinal composition based on the cationic lipid molecule. The cationic lipid molecule has the advantages of simple synthesis process and good stability, and the cationic liposome has a high efficiency (characterized by high transfection efficiency) and a low toxicity, is stable and uniform, is easy to prepare, and can be used for transferring various cell lines. The cationic lipid molecule has excellent transitivity, and can efficiently deliver active substances (such as exemplary siRNA) omto cells (such as exemplary lung cancer cells), tissues and organs to achieve efficient regulation of the active substances. The problem that the toxicity and the transfer efficiency of cationic liposome existing in the prior art are low is solved.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 35444-44-1